Heart Valve Disease Expected to Double by 2040

Early diagnosis can save lives, but many are unaware of their risk

Published on Feb. 22, 2026

Got story updates? Submit your updates here. ›

As the population ages, the American Heart Association projects that heart valve disease is expected to double by 2040 and triple by 2060. Yet many people do not know they are at risk. On Heart Valve Disease Awareness Day, the American Heart Association encourages healthcare professionals to prioritize timely diagnosis through careful clinical history and stethoscope exams to detect early warning signs before symptoms become severe.

Why it matters

Early diagnosis can expand treatment options, prevent complications, and improve quality of life for those with heart valve disease. However, women are more likely to be misdiagnosed or diagnosed later than men, highlighting the need to raise awareness among clinicians and patients.

The details

A simple but careful clinical history and precise stethoscope exam can detect early warning signs of heart valve disease before symptoms become severe. Timely echocardiograms and referrals to cardiologists can also help ensure people receive appropriate care. Discussions with patients about available treatment options, including minimally invasive procedures, support shared decision-making.

  • The American Heart Association projects heart valve disease will double by 2040 and triple by 2060.
  • Heart Valve Disease Awareness Day is held annually on February 22.

The players

American Heart Association

The world's leading nonprofit organization focused on changing the future of health for all.

Clyde W. Yancy, M.D., M.Sc., FAHA

Past volunteer president of the American Heart Association (2009–2010), co-chair of the Target: Aortic Stenosis TM Science Advisory Group, and chief of cardiology in the department of medicine at Northwestern University's Feinberg School of Medicine.

Got photos? Submit your photos here. ›

What they’re saying

“Projections show heart valve disease is on a steep rise, but too many people don't realize they're at risk. Because the condition often develops quietly, early detection is critical.”

— Clyde W. Yancy, M.D., M.Sc., FAHA, Past volunteer president of the American Heart Association (2009–2010), co-chair of the Target: Aortic Stenosis TM Science Advisory Group, and chief of cardiology in the department of medicine at Northwestern University's Feinberg School of Medicine (heart.org)

What’s next

The Association's Target: Aortic Stenosis™ initiative aims to improve timely diagnosis and appropriate treatment while providing comprehensive resources for patients and caregivers.

The takeaway

Early diagnosis and treatment are critical for everyone, yet women are more likely to be misdiagnosed or diagnosed later than men with heart valve disease. Raising awareness among clinicians and patients can help close these gaps and improve outcomes for all.